Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

coronavirus

  • Home
  •  
  • coronavirus



  • Most Read
  • Latest Comments
  • Coronavirus COVID-19 becomes an issue as Australian Reporting Season ends: Equity strategy insight
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Coronavirus COVID-19 becomes an issue as Australian Reporting Season ends: Equity strategy insight
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Coronavirus COVID-19 becomes an issue as Australian Reporting Season ends: Equity strategy insight
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Coronavirus COVID-19 becomes an issue as Australian Reporting Season ends: Equity strategy insight
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Coronavirus COVID-19 becomes an issue as Australian Reporting Season ends: Equity strategy insight
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Fed’s Interest Rate expectation policy and yield curve inversion
    Fed’s Interest Rate expectation policy and yield curve inversion
    • Opinion

  • RATs – The ASX-listed companies manufacturing Rapid Antigen Tests that you cannot buy
    RATs - The ASX-listed companies manufacturing Rapid Antigen Tests that you cannot buy
    • News

  • MedAdvisor engaged with $4m deal to promote COVID-19 vaccination
    MedAdvisor engaged with $4m deal to promote COVID-19 vaccination
    • News

  • Uscom releases ventilator calibrator as demand surges through COVID-19
    Uscom releases ventilator calibrator as demand surges through COVID-19
    • News

  • Why gold will continue to shine
    Why gold will continue to shine
    • Opinion

  • Coronavirus COVID-19 becomes an issue as Australian Reporting Season ends: Equity strategy insight
    • Opinion

    Coronavirus COVID-19 becomes an issue as Australian Reporting Season ends: Equity strategy insight

    No doubt, after many weeks with coronavirus, dubbed “COVID-19”, lingering in the background of U.S and Australian corporate reporting season, investment markets, have reacted strongly over the past week. On public health concerns and uncertainty over the economic impact, we saw a sell-off in equities and yield on “safe-haven” 10-year Treasuries being pushed to record

    Read More
    Public
  • Zoono successfully tests against coronavirus COVID-19, shares skyrocket
    • News

    Zoono successfully tests against coronavirus COVID-19, shares skyrocket

    Biotech company Zoono Group (ASX: ZNO) has reported that its lab tests against COVID-19 have shown their hand sanitiser product to have more than 99.99% efficacy in deactivating the coronavirus pathogens.  Conducted under strict European testing standards, the tests conducted identified Zoono’s Z-71 Microbe Shield hand sanitiser to be effective against a variety of pathogens

    Read More
    Public
  • With trade stalling in China, Eagle Health turns to Africa with new continental distributor
    • News

    With trade stalling in China, Eagle Health turns to Africa with new continental distributor

    As fears over the coronavirus outbreak continue to spread, health and nutritional product manufacturer Eagle Health (ASX: EHH) is set to diversify their distribution channels by entering a collaborative agreement with Amka Products which has a continental footprint throughout Africa.  The agreement will see AMKA, a market leader for manufacturing and distribution of health products

    Read More
    Public
  • Coronavirus driving dairy product sales and production, says Jatenergy
    • News

    Coronavirus driving dairy product sales and production, says Jatenergy

    Australia-China trade specialist and consumer good manufacturer Jatenergy (ASX: JAT) has reported a significant uplift in their dairy product brands with the company correlating the rise with the coronavirus breakout.  Whilst the Company did not go into any details regarding the correlation, their Neurio lactoferrin brand of milk products have seen a spike in orders

    Read More
    Public
  • Food Revolution pivots into hand sanitiser production, shares surge 49%
    • News

    Food Revolution pivots into hand sanitiser production, shares surge 49%

    With a bottling production plant already in operation, food processing company Food Revolution Group (ASX: FOD) has received enough interest in hand sanitiser to quickly commission a new bottling line to fill a global supply gap in the sanitary product.  Whilst the company does not have a line of sanitary products, its Melbourne plant has

    Read More
    Public
  • Data breach caps off horrendous few months for Asian matchmaker Love Group
    • News

    Data breach caps off horrendous few months for Asian matchmaker Love Group

    In an age when dating apps are free to download and users swipe-right uninhibited, it is a credit to Hong-Kong based matchmaker Love Group (ASX: LVE) to have still billed out $1.7m in customer receipts for H1 of FY20.  Despite the billings, Love Group has reported a cash operating loss of $228k with political protests

    Read More
    Public
  • 1
  • 2
  • 3
  • 4
  • 5

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.